Yu, Anthony F.
Dang, Chau T.
Jorgensen, Justine
Moskowitz, Chaya S.
DeFusco, Patricia
Oligino, Eric
Oeffinger, Kevin C.
Liu, Jennifer E.
Steingart, Richard M.
Funding for this research was provided by:
National Cancer Institute (K23 CA218897, P30 CA008748, P30 CA008748, P30 CA008748)
Article History
Received: 6 April 2022
Accepted: 15 February 2023
First Online: 9 March 2023
Declarations
:
: The study protocol and informed consent form have been approved by the institutional review board at Memorial Sloan Kettering. Written informed consent is obtained from all patients by study personnel prior to any study assessment.
: Not applicable.
: AFY has reported personal fees from Glenmark, Genentech, and Ichnos Sciences. CTD has reported research funding and personal fees from Genentech/Roche and Puma Technology. JEL has reported personal fees from Pfizer, Bay Labs, and Phillips. RMS has reported personal fees from Pfizer and Celgene. No other disclosures were reported.